DRUG

trelagliptin

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for trelagliptin

Inflammatory bowel disease 1

Mediator Outcome Score Tier Lit. status Trial
DPP-4 disease activity 0.220 Mid novel signal none

Clinical trials

20 registered trials for trelagliptin

Source: ClinicalTrials.gov